Drug Shortage Report for ZEVALIN
| Report ID | 123056 |
| Drug Identification Number | 02328674 |
| Brand name | ZEVALIN |
| Common or Proper name | ZEVALIN |
| Company Name | AURO PHARMA INC |
| Market Status | APPROVED |
| Active Ingredient(s) | IBRITUMOMAB TIUXETAN |
| Strength(s) | 3.2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | Kit for preparation of 90Y-Ibritumomab Tiuxetan |
| ATC code | V10XX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-12-01 |
| Actual start date | 2020-12-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-09-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2021-09-21 | French | Compare |
| v11 | 2021-09-21 | English | Compare |
| v10 | 2021-05-25 | French | Compare |
| v9 | 2021-05-25 | English | Compare |
| v8 | 2021-03-24 | French | Compare |
| v7 | 2021-03-24 | English | Compare |
| v6 | 2020-12-02 | French | Compare |
| v5 | 2020-12-02 | English | Compare |
| v4 | 2020-12-02 | English | Compare |
| v3 | 2020-08-27 | French | Compare |
| v2 | 2020-08-27 | English | Compare |
| v1 | 2020-08-27 | English | Compare |
Showing 1 to 12 of 12